51. Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin
- Author
-
Nis Halland, Mark Brönstrup, Jörg Czech, Andreas Evers, Markus Follmann, Matthias Schiell, Markus Kohlmann, Herman Schreuder, Christopher Kallus, Michael Kurz, and Werngard Czechtizky
- Subjects
Models, Molecular ,Carboxypeptidase B2 ,Swine ,Stereochemistry ,Crystallography, X-Ray ,Cyanobacteria ,Peptides, Cyclic ,Small Molecule Libraries ,Mice ,Structure-Activity Relationship ,chemistry.chemical_compound ,Microsomes ,Drug Discovery ,Hydrolase ,Animals ,Humans ,Structure–activity relationship ,Cells, Cultured ,Biological Products ,Natural product ,Molecular Structure ,biology ,Fibrinolysis ,Rational design ,Carboxypeptidase ,Small molecule ,Rats ,chemistry ,Biochemistry ,biology.protein ,Molecular Medicine - Abstract
Anabaenopeptins isolated from cyanobacteria were identified as inhibitors of carboxypeptidase TAFIa. Cocrystal structures of these macrocyclic natural product inhibitors in a modified porcine carboxypeptidase B revealed their binding mode and provided the basis for the rational design of small molecule inhibitors with a previously unknown central urea motif. Optimization based on these design concepts allowed for a rapid evaluation of the SAR and delivered potent small molecule inhibitors of TAFIa with a promising overall profile.
- Published
- 2015
- Full Text
- View/download PDF